JUN 06, 2018 5:54 AM PDT

Computer Simulations Offer Alternative Methods for Diabetic Drugs

WRITTEN BY: Nouran Amin

The Governor's Chair for Molecular Biophysics at the University of Tennessee (Knoxville), Jeremy Smith, and the director for the Center for Molecular Biophysics at Oak Ridge National Laboratory, has collaborated with a research team from UT Health Science Center to find a chemical substance that may lower glucose levels in the same efficacy as the common diabetic metformin but with the possibility of being administered in lower dose.

Smith, in collaboration with Jerome Baudry, of the University of Alabama (Huntsville) as well as graduate student Karan Kapoor, from the University of Illinois at Urbana-Champaign, studied high-performance computing to develop sophisticated simulations that suggest chemicals that could activate GPRC6A, which is protein that regulates sugar levels while at the same time corrects abnormalities in pancreatic insulin secretion, glucose uptake into skeletal muscle, and the regulation of glucose and fat metabolism in the liver.

"This chemical compound lowers sugar levels in mice as effectively as metformin, but with a 30-times lower dose," Smith said. "It therefore is a good starting point for the development of a new and effective drug to fight diabetes."

Wolrdwide, about 400 million people suffer from Type 2 diabetes. The global cost of treatment and management of this metabolic disorder is estimated to be a trillion dollars annually. Metformin, a common diabetic drug that works to reduce the liver's production of sugar and lessen the risk of mortality, is currently first-line medication treatment by physicians. However, there remains a dire need for an alternative treatment option for patients who do not respond to metformin as well as others.

 

The computations derived from the research study confirmed that multiple chemical compounds, tested each by the Quarles laboratory at UTHSC, may activate the GPRC6A protein. Furthermore, a team of UTHSC medicinal investigators utilized the results from the research study to synthesize related molecules for pre-clinical testing use. The chemical compound by the name of ‘DJ-V-159’ was identified and concluded to be highly potent in inducing insulin secretion and decreasing glucose levels in mouse models.

 

Source: University of Tennessee at Knoxville

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 16, 2020
Drug Discovery & Development
A Change of Heart
NOV 16, 2020
A Change of Heart
For a long time cardiovascular issues related to the heart muscular wall have been addressed by therapeutics that target ...
DEC 09, 2020
Technology
AI Helps Drug Combination Therapy in Cancer
DEC 09, 2020
AI Helps Drug Combination Therapy in Cancer
Healthcare providers opt to multiple of therapies for cancer patients—often containing combo drugs. Research has s ...
DEC 21, 2020
Drug Discovery & Development
Drug Increases Vaccine Responses
DEC 21, 2020
Drug Increases Vaccine Responses
A drug was found to increase the effects of vaccine responses in older adults. The drug works by removing cellular debri ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
DEC 30, 2020
Drug Discovery & Development
Gene Therapy Cures Mice of Deafness
DEC 30, 2020
Gene Therapy Cures Mice of Deafness
Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic ...
Loading Comments...